A carregar...
SUN-155 Clinical Experience of SGLT2 Inhibitors in a Hispanic Population: Should We Consider Its Use as Add-On Treatment?
Introduction: 1 in 11 adults have DM globally,(1) and Hispanics have higher complication rates.(2) A study determined that ~$16,750/year are spent by patients in medical related costs, of which ~$9,600 are related to diabetes.(3) Half of Type 2 Diabetes Mellitus (T2DM) patients aren't achieving...
Na minha lista:
| Publicado no: | J Endocr Soc |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553393/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-155 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|